Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery

The greatest challenge in developing therapies for mucopolysaccharidosis (MPS) IIIB is to achieve efficient central nervous system (CNS) delivery across the blood–brain barrier (BBB). In this study, we used the novel ability of adeno-associated virus serotype 9 (AAV9) to cross the BBB from the vascu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Fu, Haiyan, DiRosario, Julianne, Killedar, Smruti, Zaraspe, Kimberly, McCarty, Douglas M
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2011
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3129800/
https://ncbi.nlm.nih.gov/pubmed/21386820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.34
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk